Technical analysis of CalciMedica, Inc. (CALC): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the immune system and protect against cellular and tissue damage in these severe conditions.
Price Performance
| 1 month | -37.93% |
| 3 months | -47.62% |
| Year-to-date | -93.99% |
| 1 year | -87.62% |
| 3 years | -87.51% |
52-Week Range
| 52-week High | $36.00 |
| 52-week Low | $1.87 |
| Avg Volume (90d) | 209K |
Technical Indicators
| SMA 50 | $3.24 |
| SMA 200 | $8.14 |
| Beta | 1.09 |
| 30-day Volatility (annualised) | 99.0% |
| Price vs SMA 50 | -39.0% |
| Price vs SMA 200 | -75.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $14.80 | |
| 2025-11 | $21.35 | +44.3% |
| 2025-12 | $32.95 | +54.3% |
| 2026-01 | $4.50 | -86.3% |
| 2026-02 | $2.58 | -42.7% |
| 2026-03 | $2.70 | +4.7% |
| 2026-04 | $2.95 | +9.3% |
| 2026-05 | $4.09 | +38.6% |
| 2026-06 | $5.15 | +25.9% |
| 2026-07 | $5.00 | -2.9% |
| 2026-08 | $2.14 | -57.2% |
| 2026-09 | $1.98 | -7.5% |
Price
| Price | $1.98 |
| Market Cap | $6M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | -14601.07 |
| EV / EBITDA | -3521.14 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | -1.46 |
| Current Ratio | 3.58 |